510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K240279Substantially Equivalent

Vidas Tbi (Gfap, Uch-L1)

bioMerieux, Inc., Hazelwood MO / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K240279 is the FDA 510(k) clearance record for VIDAS TBI (GFAP, UCH-L1), a class II device, cleared for bioMerieux, Inc. on under FDA product code QAT (Brain Trauma Assessment Test). FDA's definition for product code QAT reads: "Intended for in vitro diagnostic use as an aid in the evaluation of patients with suspected mild traumatic brain injury (TBI) in conjunction with other clinical information to assist in determining the need for radiologic (e.g., CT, MR)...". FDA records list 408 510(k) clearances for bioMerieux, Inc., from to . As of , FDA records show no recalls naming K240279.

Clearance record

Decision date
Received
(90 days to decision)
Product code
QAT Brain Trauma Assessment Test
Regulation
21 CFR 866.5830
Device class
Class II
Review panel
Immunology
Applicant
bioMerieux, Inc. 595 Anglum Rd., Hazelwood MO
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QAT

Trailing 12 months

FDA records hold no clearances under product code QAT in the trailing twelve months.

FDA records show no clearances under product code QAT in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code QAT, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260